A detailed history of Ethos Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ethos Financial Group, LLC holds 2,523 shares of ABT stock, worth $294,156. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,523
Previous 2,795 9.73%
Holding current value
$294,156
Previous $290,000 1.03%
% of portfolio
0.05%
Previous 0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$100.07 - $118.13 $27,219 - $32,131
-272 Reduced 9.73%
2,523 $287,000
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $3,223 - $3,598
32 Added 1.16%
2,795 $290,000
Q1 2024

May 08, 2024

SELL
$109.52 - $120.96 $7,666 - $8,467
-70 Reduced 2.47%
2,763 $314,000
Q4 2023

Feb 07, 2024

BUY
$90.19 - $110.4 $65,026 - $79,598
721 Added 34.14%
2,833 $312,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $201,759 - $242,077
2,112 New
2,112 $204,000
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $201,051 - $235,864
2,115 New
2,115 $237 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $204B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ethos Financial Group, LLC Portfolio

Follow Ethos Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethos Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ethos Financial Group, LLC with notifications on news.